In NIH trial, selumetinib shrinks tumors, pr ovides clinical benefit for children with NF1

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Update Your E-mail Address | Add Subscriptions | Unsubscribe

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health